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Florida red tides annually occur in the Gulf of
Mexico and result from blooms of the marine
dinoflagellate Karenia brevis. K. brevis produces
highly potent natural polyether toxins, known
as brevetoxins, that activate voltage-sensitive
sodium channels. Studies in experimental ani-
mals have shown that brevetoxins can cause
upper and lower respiratory irritation. The two
known clinical entities in humans that are
associated with red tide toxins, first character-
ized in Florida, are acute gastroenteritis with
neurologic symptoms after ingestion of conta-
minated shellfish [i.e., neurotoxic shellfish poi-
soning (NSP)] and an apparently reversible
upper respiratory syndrome after inhalation of
the Florida red tide aerosols (Asai et al. 1982;
Backer et al. 2003; Baden et al. 1995; Cheng
et al. 2005a; Fleming et al. 2001, 2005; Morris
et al. 1991; Music et al. 1973; Pierce et al.
2003; Poli et al. 2000). Anecdotal reports and
a prior study of recreational beachgoers have
indicated that the inhalation of the aerosols
associated with Florida red tide leads to both
upper and lower respiratory symptoms, possi-
bly with chronic health implications (Backer
et al. 2003; Kirkpatrick et al. 2004).
Respiratory effects from exposure to
Florida red tides or pure brevetoxins have been
reported in experimental animals. Franz and
LeClaire (1989) reported respiratory failure in
less than 30 min in guinea pigs exposed intra-
venously to 0.016 ng/kg of brevetoxin 3.
Benson et al. (1999) exposed 12-week-old
male F344/Crl BR rats once to 6.6 µg/kg
brevetoxin 3 through intratracheal instillation.
The researchers concluded that the potential
adverse health effects associated with inhaled
brevetoxins could extend beyond the report-
edly transient respiratory irritation to long-
term impacts on asthma. Wells et al. (1984)
reported increased airway resistance in Hartley
guinea pigs when brevetoxin was inhaled as an
aerosol or applied to the nares as nose drops.
In unanesthestized asthmatic sheep, intra-
tracheal instillation of picogram doses of breve-
toxin 3 can cause a significant and rapid
increase in airway resistance; this brevetoxin-
induced bronchospasm can be effectively
blocked by atropine, the mast cell–stabilizing
agent cromolyn, the histamine H1 antagonist
chlorpheniramine, and the β2 agonist albuterol
(Abraham et al. 2003, 2005; Baden et al.
2005; Benson et al. 2005; Singer et al. 1998).
Thus, aerosolized brevetoxins appear to be
potent respiratory toxins, involving both
cholinergic and histamine-related mechanisms.
This article is part of the mini-monograph
“Aerosolized Florida Red Tide Toxins (Brevetoxins).”
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Florida red tides annually occur in the Gulf of Mexico, resulting from blooms of the marine
dinoflagellate Karenia brevis. K. brevis produces highly potent natural polyether toxins, known as
brevetoxins, that activate voltage-sensitive sodium channels. In experimental animals, brevetoxins
cause significant bronchoconstriction. A study of persons who visited the beach recreationally
found a significant increase in self-reported respiratory symptoms after exposure to aerosolized
Florida red tides. Anecdotal reports indicate that persons with underlying respiratory diseases may
be particularly susceptible to adverse health effects from these aerosolized toxins. Fifty-nine per-
sons with physician-diagnosed asthma were evaluated for 1 hr before and after going to the beach
on days with and without Florida red tide. Study participants were evaluated with a brief symp-
tom questionnaire, nose and throat swabs, and spirometry approved by the National Institute for
Occupational Safety and Health. Environmental monitoring, water and air sampling (i.e., K. brevis,
brevetoxins, and particulate size distribution), and personal monitoring (for toxins) were per-
formed. Brevetoxin concentrations were measured by liquid chromatography mass spectrometry,
high-performance liquid chromatography, and a newly developed brevetoxin enzyme-linked
immunosorbent assay. Participants were significantly more likely to report respiratory symptoms
after Florida red tide exposure. Participants demonstrated small but statistically significant
decreases in forced expiratory volume in 1 sec, forced expiratory flow between 25 and 75%, and
peak expiratory flow after exposure, particularly those regularly using asthma medications. Similar
evaluation during nonexposure periods did not significantly differ. This is the first study to show
objectively measurable adverse health effects from exposure to aerosolized Florida red tide toxins
in persons with asthma. Future studies will examine the possible chronic effects of these toxins
among persons with asthma and other chronic respiratory impairment. Key words: asthma, breve-
toxins, COPD, harmful algal blooms (HABs), Karenia brevis, red tides, sensitive populations,
spirometry. Environ Health Perspect 113:650–657 (2005). doi:10.1289/ehp.7500 available via
http://dx.doi.org/ [Online 10 February 2005]
Multiple die-offs of marine mammals,
particularly the endangered Florida manatee,
have been reported in association with Florida
red tide and brevetoxins (Bossart et al. 1998).
These die-offs probably resulted from expo-
sure to brevetoxins with prolonged inhalation
of the red tide toxin aerosol and/or the inges-
tion of contaminated seawater over several
weeks. Necropsies of the dead manatees
revealed severe catarrhal rhinitis, pulmonary
hemorrhage and edema, and nonsuppurative
leptomeningitis, as well as possible chronic
hemolytic anemia with multiorgan hemo-
siderosis and evidence of neurotoxicity.
Few reports have been published about
possible adverse health effects associated with
exposure to aerosolized red tide toxins in
humans. After initial cases in Florida and
Texas, Woodcock (1948) reported respiratory
irritation during a severe red tide on the west
coast of Florida in 1947. The exposure usually
occurs on or near beaches during an active red
tide bloom. Onshore winds and breaking surf
result in the release of the toxins into the water
and into the onshore aerosol (Pierce and
Kirkpatrick 2001). Collection of marine
aerosol along the gulf coast of Florida and the
North Carolina Atlantic coast during natural
red tide blooms showed that the aerosolized
toxins were the same as those in the water and
as those identified in the K. brevis cultures
(Pierce et al. 1990). Aerosolized brevetoxin
concentrations, particle size, and exposure level
were measured in a recent Florida red tide
episode in Texas associated with respiratory
symptoms in humans (Cheng et al., 2005a;
Pierce et al. 2003). The mass median aero-
dynamic diameters were 7–9 µm, a relatively
large size for inhaled ambient particles.
In humans, inhalation of aerosolized red
tide toxins reportedly results in conjunctival
irritation, copious catarrhal exudates, rhinor-
rhea, nonproductive cough, and wheezing (Asai
et al. 1982; Backer et al. 2003; Cheng et al.,
2005a; Kirkpatrick et al. 2001, 2004; Music
et al. 1973 ). The normal population can
reportedly rapidly reverse the irritation and
wheezing by leaving the beach area or enter-
ing an air-conditioned area (Baden 1983;
Steidinger and Baden 1984). However, persons
with asthma apparently are particularly suscep-
tible to aerosolized Florida red tide and its tox-
ins. In addition to anecdotal reporting, Asai
et al. (1982) found that 80% of 15 persons
with asthma exposed to red tide aerosol at the
beach complained of subsequent asthma
attacks. The possible susceptibility of persons
with asthma to aerosolized brevetoxins is cor-
roborated by recent investigations with an asth-
matic sheep model evaluating the exposure of
aerosolized red tide toxins, as discussed above
(Abraham et al. 2003, 2005; Singer et al. 1998).
This report presents the initial evaluation
of the exposures and effects of aerosolized
Florida red tide toxins in persons with prior
physician-diagnosed asthma during 1 hr of
exposure to a Florida red tide and during 1 hr
of nonexposure.
Materials and Methods
This study was part of the ongoing evaluation
of the possible acute and chronic adverse health
effects from exposure to aerosolized Florida red
tide toxins (brevetoxins) by an interdisciplinary
team of researchers from federal, state, private,
and local organizations. These studies have
received approval from the institutional review
boards of the University of Miami School of
Medicine, the Centers for Disease Control and
Prevention, and the Florida Department of
Health. The location for the study was Siesta
Beach in Sarasota, Florida.
Environmental monitoring. As described
by Cheng et al. (2005b) and Pierce et al. (in
press), a portable, self-contained weather sta-
tion was used near the high-volume impactor
sampling locations to monitor the air temper-
ature, relative humidity, and wind speed and
direction (Complete Weather Station; Davis
Instruments, Hayward, CA). The weather sta-
tion was solar powered, and the data were
downloaded into a notebook computer.
Water samples were collected daily in 1-L
glass bottles at 0800, 1200, and 1600 hr from
the surf zone adjacent to the study’s high-vol-
ume air sampler locations. A 20-mL subsample
was taken from each bottle and fixed with
Utermohl’s solution to provide K. brevis cell
counts. The remaining water sample was trans-
ported to Mote Marine Laboratory and
processed for liquid chromatography–mass
spectrometry (LC-MS) analysis according to
the procedure of Pierce et al. (2003). A sub-
sample of each extract was shipped to the
University of North Carolina at Wilmington
Center for Marine Research for brevetoxin
analysis using a new brevetoxin enzyme-linked
immunosorbent assay (ELISA) method.
In the laboratory, brevetoxins were
extracted by passing the water through a C-18
solid-phase extraction disk under vacuum
(Ansys Technologies, Inc., Lake Forest, CA).
The C-18 disks then were rinsed with reverse
osmosis water to remove any remaining salts
and eluted with methanol (Pierce et al. 2003).
Brevetoxin analyses were performed by
LC-MS using a ThermoFinnigan AqA high-
performance liquid chromatography–MS
(HPLC-MS; Thermo Electron Corp.,
Manchester, UK). Mass spectral detection
was obtained using an AqA single-quad sys-
tem scanned from 204 to 1,216 AMU with
AqA Max 40 V electrospray. The column was
Phenomenex Luna C-18 5Fm 250 × 2 mm
(Phenomenex, Torrance, CA); the solvent
gradient was 0.3% acetic acid/H2O with ini-
tial 50:50 acetylnitrile (ACN)/H2O to
95:5 ACN/H2O over 30 min. The limit of
detection (LOD) of the analysis for brevetox-
ins in seawater was 0.03 µg/L (Cheng et al.
2005b; Pierce et al. in press).
Air samples were collected using three
different instruments: high-volume air sam-
plers, high-volume air samplers equipped to
capture aerosol particles by size, and personal
breathing zone samplers. Brevetoxins were
collected in air samples along Siesta Beach.
Six high-volume air samplers (TE-5000;
Tisch Environmental, Inc., Village of Cleaves,
OH) with a single-stage filter were used; three
were placed near the surf zone (about 25 m)
approximately 100 m apart, and a second row
of three was located approximately 50 m from
the first row for assessment of aerosolized
toxin concentrations over time and space
along the beach. Two additional high-volume
air samplers with five-stage impactors were
deployed in the first row to obtain the distrib-
ution of toxin-containing aerosol particle size.
Filter samples were collected separately
for morning and afternoon time periods
(0830–1200 hr and 1230–1600 hr). The
impactor samplers were operated from morn-
ing to afternoon to collect enough material
for analysis. Personal exposure was measured
on volunteers wearing a personal sampler
(IOM inhalable dust sampler; SKC, Inc.,
Eighty Four, PA) connected to a battery-
operated pump (model 224-PCXR4; SKC,
Inc.) while they were at the beach. The per-
sonal sampler was placed at the lapel near the
breathing zone. A 25-mm glass-fiber filter
(type A/E; Pall Life Science, Ann Arbor, MI)
was used as the collection substrate. The sam-
pling flow rate was 2 L/min controlled by a
rotameter in the sampling pump (Cheng et al.
2005b; Pierce et al., in press).
The high-volume air samplers used to
detect aerosolized brevetoxins were fitted with
a 20.32 cm × 25.4 cm glass-fiber filter
(EPM2000; Whatman, Maidstone, UK).
Brevetoxins associated with marine aerosols
were recovered from glass-fiber filters by
extraction for 12 hr in acetone using a Soxhlet
apparatus (Pierce et al. 2003). The extract was
then transferred to vials using methanol for
LC-MS and ELISA analysis. Brevetoxin recov-
ery from glass-fiber filters was verified by the
addition of standard amounts of brevetoxin 2
and brevetoxin 3 to each of three filters that
were subsequently processed for LC-MS analy-
ses. Cellulose filters from impactor samplers
were cut in half and rolled into a 15-mL
polypropylene tube (second half of filter was
stored). Ten milliliters of acetone was added to
the tube; then the sample was vortexed for
20-sec, sonicated for 2-min, and then placed
on a circular rotator (Roto-Torque, low
speed-10; Cole-Parmer Instruments, Vernon,
IL) for 20-min. The 10 mL of extract then was
evaporated under a gentle stream of nitrogen to
approximately 100 µL, vortexed for 5 sec to
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rehomogenize the extract, and recombined
with 50:50 methanol:purified water to the final
analysis volume (typically 200 µL) (Cheng
et al. 2005a; Pierce et al., in press). The sam-
ples then were analyzed for brevetoxins by an
LC-MS technique using an HPLC (SIL-DAD
vp; Shimadzu Co., Kyoto, Japan) coupled with
the API 365 MS/MS (Applied Biosystems Inc.,
Foster City, CA) (Cheng et al. 2005a; Pierce
et al., in press). The LOD for the analysis of
impactor samples was 0.01 ng/m3.
Concentrations of brevetoxins on portions
of the ambient air filters and the personal
breathing zone filters, as well as the nasal and
throat swabs, were also analyzed by a recently
developed competitive ELISA (Naar et al.
2002). Air filters (personnel and aliquots of
environmental air filters) were sonicated for
15 min in ELISA buffer (0.1 M phosphate-
buffered saline, pH 7.4, 0.5% gelatin,
0.1% Tween 20). Nose and throat swabs were
sonicated for 45 min in ELISA buffer. The son-
icated material was analyzed directly according
to the brevetoxin ELISA protocol (Naar et al.
2002). The limit of quantification of the breve-
toxins using the ELISA was 0.6 ng/sample (air
filter and/or nasal/throat swab).
Adverse human health effects. Persons at
least 12 years of age who reported a physi-
cian’s diagnosis of asthma were recruited as
study participants in Sarasota, Florida, an area
with a history of annual Florida red tides. All
participants who gave informed consent to
participate walked on the beach once during a
Florida red tide and also walked once when no
Florida red tide was present. Participants were
instructed to maintain their daily regime for
asthma control. They were asked to spend a
minimum of 1 hr at the beach in areas where
environmental monitoring was ongoing and
were told they could leave the beach at any
time if they felt uncomfortable or sympto-
matic and could freely use any personal med-
ications. Study activities included the pre- and
postexposure questionnaires, swab sampling,
and spirometry, as well as carrying a personal
air monitor while at the beach.
Questionnaires were administered upon
enrollment and then before and after the par-
ticipants visited the beach. The questionnaires
collected information about demographics,
baseline pulmonary health history, prior expe-
rience with Florida red tide, medications,
potential confounders, and symptoms. In
addition to asking about expected common
respiratory symptoms, the questionnaire asked
about diarrhea to detect overreporting bias,
because diarrhea was not expected to be asso-
ciated with exposure to aerosolized Florida red
tide (vs. ingestion exposure resulting in NSP).
For the purposes of analysis, age groups were
evaluated as tertiles (< 18 years, 18–60 years,
> 60 years). Geographic proximity of residence
to the beach also was explored; proximity was
defined as residence on a barrier island or
along Sarasota Bay (i.e., within approximately
1 mile of the seashore). The investigators con-
sidered two surrogate measures of asthma
severity: above and below the unexposed
period study population mean forced expira-
tory volume in 1 sec (FEV1) and the use of
asthma medications (predominantly β2 ago-
nists) within 12 hr before going to the beach.
However, the mean FEV1 before the unex-
posed beach visit was not considered to be a
good measure of disease severity and was not
used: no untreated baseline was obtained
before the unexposed beach visit, and in the
study population, persons who used asthma
medication within 12 hr before going to the
beach, were more likely to have an FEV1 value
greater than the mean FEV1 from the unex-
posed period (data not shown). Therefore,
only the use of asthma medications within
12 hr before going to the beach was used as a
surrogate for increased asthma severity.
Spirometry tests were performed using a
portable OMI2000 10-L dry-rolling-seal vol-
ume spirometer (Occupational Marketing,
Inc., Houston, TX) by personnel trained
according to the standards of the National
Institute for Occupational Safety and Health
(NIOSH 1997). The spirometric values of
interest were FEV1, forced vital capacity
(FVC), forced expiratory flow between 25
and 75% (FEF25–75, peak expiratory flow
(PEF), and FEV1/FVC percentage. For the
purposes of this study, each participant served
as his or her own spirometry control (i.e., pre-
exposure/postexposure); all study participants
had at least three reproducible spirograms
before and after visiting the beach. The data
were considered adequate if they conformed
to standard guidelines for the collection and
interpretation of spirometry measurements
(American Thoracic Society 1991, 1995;
Hankinson et al. 1999).
As an effect biomarker of inflammation,
nose and throat swabs were collected from the
study participants before and after they went to
the beach. Samples were obtained by gently
wiping the nose or throat with a cotton-tipped
swab, smearing the material onto duplicate
microscope slides, and fixing with a cytologic
adhesive spray (Spray-Cyte; Becton Dickinson,
Sparks, MD). One slide from each pair was
stained using Diff Quik (Dade Behring Inc.,
Newark, DE) for cytologic evaluation of
epithelial and inflammatory cells. The inflam-
matory response was characterized according to
cellularity and the percentage of neutrophils
and chronic inflammatory cells (e.g., macro-
phages, lymphocytes, and plasma cells). In
addition, protein transudation and amount of
fibrin present were evaluated because increas-
ingly permeable cell membranes, a key event in
the inflammatory process, lead to protein tran-
sudation as proteins leak out of the cells. As
described above, brevetoxin levels also were
analyzed by a newly developed brevetoxin
ELISA (Naar et al. 2002) on the nasal and
throat swabs as an exposure biomarker.
Statistics. A study database was created in
Microsoft Access. Descriptive and other statis-
tical analyses were performed using SAS statis-
tical software (version 8.03; SAS Institute Inc.,
Cary, NC). Statistical hypothesis testing was
performed using the paired t-test for continu-
ous data and the McNemar’s test for categori-
cal data (Kleinbaum et al. 1982) to compare
pre- and postexposure data. The number of
persons reporting no symptom before going
on the beach but reporting the particular
symptom after exposure was compared with
the number who reported no symptoms
before and after their beach walk. Because this
was an initial evaluation of the possible human
adverse health effects of Florida red tide air-
borne toxin exposure, it was considered
hypothesis generating. Therefore, multiple
comparisons were not adjusted for in the level
of statistical significance.
Results
The results contrast the environmental moni-
toring and human adverse health effects evalu-
ations collected during 3 days when study
participants were exposed to the Florida red
tide aerosol (exposed sampling period, March
2003) with similar data collected during 3 days
when no Florida red tide occurred (unexposed
sampling period, January 2003).
Environmental data. Environmental sam-
pling confirmed the presence of K. brevis and
brevetoxins in the water and air during the
Florida red tide exposed period, and the lack
of significant toxin and organism levels in the
water and air during the Florida red tide unex-
posed evaluation (Table 1). Surf water samples
from the unexposed period exhibited K. brevis
cell counts ranging from none detected
(< 1,000 cells/L) to a high of 6,000 cells/L on
17 January 2003, diminishing to < 1,000
cells/L on 18 January. During this time, water
samples contained low concentrations of
brevetoxins, ranging from none detected
(< 0.05 µg/L) to 2.0 µg/L for samples col-
lected on both days. High-volume air samplers
recovered only trace amounts of brevetoxins
from the air on 17 January, with none
detected (< 0.5 ng/m3) on 18 January.
Water samples collected during the
Florida red tide exposed period showed mod-
erate to high concentrations of K. brevis cells
(daily mean ± standard deviation) on the first
day of the exposed study, 29 March 2003
(181,000 ± 131,000 cells/L). Cell concentra-
tions increased on the second day of exposed
study on 30 March (764,000 ± 264,000
cells/L) and remained high through 31 March
morning (236,000 ± 69,000 cells/L), then
diminishing rapidly by the 1200 hr sample
Mini-Monograph | Fleming et al.
652 VOLUME 113 | NUMBER 5 | May 2005 • Environmental Health Perspectives
collection (22,000 ± 11,000 cells/L). The
mean total brevetoxin concentration in water
samples on 29 March was 3.4 ± 1.9 µg/L
throughout the day. Toxin concentrations in
water were higher on 30 March, with a mean
and standard deviation of 14 ± 8 µg/L, dimin-
ishing again to 3.3 ± 3.7 µg/L on 31 March.
In addition to temperature and relative
humidity, wind speed and wind direction were
measured. Both wind speed and wind direction
are essential in the production and transport of
the red tide aerosol to the beach. During the
unexposed Florida red tide period, wind direc-
tion during the sampling was offshore. This
and low brevetoxin concentration in water
resulted in only trace or undetectable amounts
of brevetoxin concentration in the air. During
the first 2 days of the exposed Florida red tide
period, the wind direction was partially
onshore with medium to high concentrations
of brevetoxins in water. These environmental
conditions produced medium levels of breve-
toxins in the air. On 31 March, the last day of
the exposed Florida red tide period, the wind
direction changed to offshore wind, and the air
concentration of brevetoxins was much lower.
By LC-MS analyses, concentrations of
brevetoxins in the air samples were found
throughout the first day of the study, 29 March,
with an overall daily mean and standard devia-
tion of 37 ± 18 ng/m3. Samples collected near
the surf did not differ from those collected
50 m up the beach, probably because of the
strong winds rapidly dispersing the toxins, pro-
viding uniform exposure over the beach study
area. Aerosolized brevetoxin concentrations in
the ambient air diminished on 30 March to
< 1/10th that observed on the first day of the
exposed study, with none detected in air sam-
ples on 31 March, even though the cell counts
and brevetoxin concentrations remained high
in the water. This probably occurred because of
a shift in wind direction from onshore to along-
shore and offshore.
ELISA analyses detected no brevetoxins
on either the swabs or the personal monitor-
ing during the unexposed study period
(January 2003). In the exposed study period
(March 2003), brevetoxins were detected in
seawater, environmental and personnel air
monitoring filters, and nose swabs of some of
the participants by ELISA. However, in initial
experimental analysis, the presence of toxins
in nose swabs did not appear to be simply
correlated with the amount of toxin that par-
ticipants were exposed to in their breathing
zone (i.e., the toxin levels measured on per-
sonnel air monitoring filters). During the
other 2 days of the Florida red tide exposed
period, toxin levels in the sea spray at the
beach were too low to be detected on air per-
sonnel filters and/or on nose swabs with the
brevetoxin ELISA.
The particle size distribution from the
impactor sample could be represented by a
log-normal distribution. The mass median
aerodynamic diameter was 6.54 ± 1.34 µm,
with a geometric standard deviation of 1.73 ±
0.05 µm.
Adverse health effects. Of the 130 persons
initially enrolled in the study of sensitive sub-
populations, 59 who had asthma participated
in study activities during both an unexposed
(January 2003) and an exposed (March 2003)
study period evaluation. Their mean age was
35.8 ± 18.7 years (range, 12–69 years); most
were white non-Hispanic women (Table 2).
This population was relatively healthy, with
very few current smokers [5 (8.5%)]; however,
11 (19.6%) had been hospitalized at least once
in the past year for pulmonary reasons. Most
(93.2%) of these participants reported variable
use of asthma medications (predominantly β2
agonists) and had experienced a Florida red
tide with reported symptoms (82.3%).
During the unexposed period, the 59 par-
ticipants who had asthma experienced neither
significant respiratory impairment nor develop-
ment of symptoms after being at the beach for
1 hr. The participants were significantly more
likely to report symptoms and significantly
more likely to have a measurable respiratory
impairment on spirometry after going to the
beach for 1 hr during a Florida red tide expo-
sure (Table 3), although there was considerable
variation in the respiratory function during the
January 2003 unexposed period. The signifi-
cant symptoms reported only during active
exposure to Florida red tide included respira-
tory complaints of cough (p < 0.01), wheezing
(p < 0.03), and chest tightness (p < 0.02), as
well as throat (p < 0.02) and eye irritation
(p < 0.01). Participants did not report diarrhea
(p = 1.00). Statistically significant decreases in
respiratory function during the Florida red tide
exposed period were measured for the FEV1
(38.0 ± 118.0 mL; p < 0.02) and the FEF25–75
(95.0 ± 296.0 mL/sec; p < 0.02) with signifi-
cant change from preexposure. No significant
changes in the FVC or FEV1/FVC percentage
were seen.
The association between symptoms and
change in FEV1 during Florida red tide expo-
sure was evaluated as a) greater or less than the
mean change in FEV1 (i.e., preexposure minus
postexposure FEV1) and b) as a positive change
(i.e., preexposure > postexposure FEV1) vs.
negative change (i.e., preexposure < post-
exposure FEV1). Participants with a decrease in
FEV1 after exposure to Florida red tide
reported statistically significant increased
coughing (p < 0.04) and borderline increased
difficulty breathing (p < 0.06) and chest heavi-
ness (p < 0.06). However, asthmatics with an
increase in FEV1 after exposure to Florida red
tide reported a statistically significant increased
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Table 1. Environmental conditions and concentrations of brevetoxins in water and air samples during the unexposed and exposed sampling periods.
Predominant Brevetoxin
Temperature Humidity Average wind wind direction K. brevis Seawater Air
Date (°C) (%) speed (km/hr) (% onshore) (cells/L) (µg/L) (ng/m3)
Unexposed
17 January 2003 12.2 ± 1.6 68 ± 5 25.6 ± 3.4 Offshore (1%) 2,400 ± 1400 < LOD < LOD
18 January 2003 8.3 ± 1.6 47 ± 5 10.9 ± 3.7 Offshore (4%) < LOD < LOD < LOD
19 January 2003 13.3 ± 1.1 53 ± 7 12.4 ± 4.0 Offshore (2%) < LOD < LOD < LOD
Exposed
29 March 2003 24.4 ± 0.5 83 ± 4 10.5 ± 5.4 Partly onshore (58%) 180,600 ± 131,000 3.44 ± 1.93 36.57 ± 17.51
30 March 2003 18.9 ± 2.2 84 ± 6 24.9 ± 6.0 Partly onshore (44%) 764,400 ± 263,700 14.01 ± 8.06 3.71 ± 2.63
31 March 2003 12.8 ± 1.1 32 ± 12 22.7 ± 2.6 Offshore (0%) 96,300 ± 86,400 3.31 ± 3.74 < LOD
Table 2. Demographics of 59 physician-diagnosed asthmatic study participants.a
Variable Asthmatics [n (%)]
n 59
Age ± SD (range in years) 35.8 ± 18.7 (12.0–69.0)
Female 34 (57.6%)
Race–ethnicity
White (%) 58 (98.3%)
Hispanic (%) 2 (3.4%)
Years with diagnosis ± SD 18.2 ± 14.9
Using asthma medications currentlyb 55 (93.2%)
Positive history of red tide symptoms with exposure 37 (82.2%)
Current smoker 5 (8.5%)
Number hospitalized in ≥ 1 in past year from respiratory causes 11 (19.6%)
aBased on baseline questionnaire information. bPredominantly β2 agonists.
chest heaviness (p < 0.01) but no other respira-
tory symptoms. Of note, reporting a cough
(not wheezing) after going to the beach was
associated with statistically significant decreases
in the PEF (p < 0.03) for asthmatics only
during the Florida red tide exposed period.
Because the participants lived in an area
with annual and often continuous Florida red
tides, there was the possibility that their
decreased respiratory function before the
study beach walk existed because of some
prior exposure (e.g., a prior Florida red tide
exposure). This possibility was examined by
comparing the pulmonary function before the
beach walk during the unexposed time period
with the pulmonary function before the beach
walk during the Florida red tide exposed
period. No significant differences were found
between FEV1, FEF25–75, PEF, FVC, or
FEV1/FVC values before the unexposed
beach walk and those before the exposed
beach walk. In fact, the mean pulmonary
function was slightly better before the beach
walk during the Florida red tide exposed
period than it was before the unexposed
period (data not shown).
Asthmatics who lived away (> 1 mile)
from the seashore were significantly more
likely to report respiratory symptoms after
going to the beach during the Florida red tide
exposed period, whereas those who lived close
(i.e., within ≤ 1 mile) to the seashore had no
statistically significant increase in reported
symptoms. Asthmatics who lived far from the
beach also were significantly more likely to
experience a decrease in FEV1 (48.0 ±
122.3 mL; p < 0.01) and FEF25–75 (104.1 ±
254.7 mL/sec; p < 0.009) with significant
change after beach exposure to Florida red
tide. Respiratory function did not differ in
asthmatics who lived close to the beach dur-
ing the Florida red tide exposed period.
The day with the highest Florida red tide
exposure by air environmental monitoring
(29 March) was examined, although only
29 asthmatics were evaluated on that day.
Reported symptoms and pulmonary function
did not change significantly during their
unexposed evaluations. During the Florida
red tide exposed period, these participants
reported significantly more cough (p < 0.02)
after returning from the beach, and there was
a statistically significant decrease in FEF25–75
(116.9 ± 272.9 mL/sec; p < 0.04).
Additional analyses determined whether
other factors such as age, gender, and severity
of illness were important with regard to
reported symptoms and spirometry before
and after going to the beach (data not
shown). Only the 18- to 60-year-old partici-
pants had statistically significant increases in
reported respiratory symptoms during the
Florida red tide exposed period, but not in
the unexposed period. Age was not associated
with any significant changes in spirometry in
the unexposed period, but during the Florida
red tide exposed period, only asthmatics
18–60 years of age had statistically significant
decreases in FEV1 (p < 0.04), FEF25–75
(p < 0.03), and PEF (p < 0.05) after going to
the beach. No significant differences for the
symptoms were reported by gender during
the unexposed period; during the Florida red
tide exposed period, female asthmatics
reported significantly more respiratory symp-
toms after going to the beach. During the
exposed period, there were statistically signifi-
cant decreases in FEV1 (p < 0.009) and
FEF25–75 (p < 0.05) for female asthmatics, as
well as statistically significant decreases in
FEV1 (p < 0.02) during the unexposed
period; male asthmatics had no statistically
significant changes during the Florida red tide
exposed or unexposed periods.
To explore asthma severity, the surrogate
measure was used to compare those asthmatics
who did and did not use asthma medications
within the 12 hr before going to the beach.
More persons [42 (58%)] reported using
asthma medication within 12 hr before going
to the beach during the exposed to Florida red
tide time period than during the unexposed
time period [30 (42%)]. The use of asthma
medications within 12 hr before going to the
beach was associated with statistically signifi-
cant increased report of cough (p < 0.004) and
chest heaviness (p < 0.04) after going to the
beach during the Florida red tide exposed
period only. The reported use of asthma med-
ications 12 hr before the beach walk was asso-
ciated with no changes in the unexposed
period, but with statistically significant
changes in the FEV1 (45.0 ± 100.1 mL;
p < 0.02), FEF25–75 (120.0 ± 299.3 mL/sec;
p < 0.03), and PEF (160.0 ± 435.7 mL/sec;
p < 0.04) during the Florida red tide exposed
period. Asthmatic females [22/34 (65%)] were
more likely to report using medication before
going to the beach compared with males
[10/25 (40%)]; female asthmatics using med-
ications experienced statistically significant
decreases in their pulmonary function during
the Florida red tide exposed period, particu-
larly FEV1 (78.0 ± 93.6 mL; p < 0.0008) and
FEF25–75 (166.4 ± 423.7 mL/sec; p < 0.04).
Asthmatics of both genders who lived far from
the beach were more likely to report taking
medication before going to the beach [25 of
44 (57%)] compared with those who lived
close to the beach [7 of 15 (47%)]; these same
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Table 3. Self-reported symptoms and spirometry results for study participants preexposure and postexposure to beach.
No red tide exposure Red tide exposure
Preexposure = no Pre- vs. post- Preexposure = no Pre- vs. post-
Postexposure = yes difference Postexposure = yes difference
Reported symptom (n) significancea (n) significancea
Respiratory
Cough 9 0.44 15 0.01
Wheezing 4 0.74 7 0.03
Shortness of breath 7 0.56 8 0.06
Chest tightness 8 0.25 17 0.002
Other
Throat irritation 5 0.56 12 0.02
Nasal congestion 6 0.76 12 0.25
Eye irritation 3 1.00 9 0.01
Headache 5 0.26 6 0.06
Itchy skin 1 0.32 1 0.56
Diarrhea 0 0 1 1.00
Prebeach Mean difference Significance Prebeach Mean difference Significance
Spirometry value mean ± SD ± SD postexposure (p-Value)b mean ± SD ± SD postexposure (p-Value)b
FEV1 3.01 ± 0.88 L 21.0 ± 139.0 mL 0.24 3.03 ± 0.87 L 38.0 ± 118.0 mL 0.02
FVC 4.02 ± 1.07 L 2.0 ± 179.0 mL 0.93 4.04 ± 1.03 L 35.0 ± 176.0 mL 0.13
FEV1/FVC 75% ± 9% 0.6% ± 3% 0.09 75% ± 9% 0.3% ± 3% 0.48
FEF25–75 2.48 ± 1.19 L/sec 39.0 ± 332.0 mL/sec 0.36 2.53 ± 1.26 L/sec 95.0 ± 296.0 mL/sec 0.02
PEF 7.56 ± 2.02 L/sec 42.0 ± 693.0 mL/sec 0.64 7.59 ± 2.02 L/sec 81.0 ± 458.0 mL/sec 0.18
aMcNemar’s test. bPaired t-test.
asthmatics were more likely to experience sta-
tistically significant decreases in their pul-
monary function during the Florida red tide
exposed period, particularly FEV1 (57.6 ±
104.9 mL; p < 0.01) and FEF25–75 (132.0 ±
273.6 L/sec; p < 0.02). The seven asthmatics
taking medication who lived near the beach
experienced a statistically significant decrease
in PEF (430.0 ± 394.0 mL; p < 0.03) during
the Florida red tide exposure period.
Swabs. The 59 asthmatics were sampled by
nasal and throat swabs both when unexposed
(January 2003) and exposed to Florida red tide
(March 2003). The Florida red tide exposed
swab data were compared with the unexposed
swab data. Several parameters were evaluated
(i.e., inflammation between pre- and post-
beach walk samples, protein transudation,
amount of fibrin present in the sample, and
percentage of reactive cells). These parameters
were all higher, although not statistically signif-
icant (chi square, 0.1 > p > 0.05), on the sec-
ond exposed day (30 March) than throughout
the unexposed period when no Florida red tide
was present. Analyses among the 3 days of
Florida red tide exposure indicated that the
swab samples on the second exposed day
(30 March) showed the greatest increase in
inflammatory response within the day (i.e.,
postexposure samples contained a greater
inflammation than preexposure sample); the
first exposed day (29 March) was intermediate,
and the last exposed day (31 March) had the
least increase in inflammation. On the second
exposed day, more (although again not statisti-
cally significant) protein and fibrin and a larger
percentage of reactive epithelial cells were
found (chi square, 0.1 > p > 0.05) in the sam-
ples than on the other days.
Discussion
This is the first study to demonstrate measur-
able adverse health effects, both in terms of
reported symptoms and objectively measured
respiratory decreases, from exposure to
aerosolized Florida red tide toxins in persons
with asthma. In addition, this study documents
the water and air exposures to the aerosolized
Florida red tide toxins associated with these
adverse health effects. This study shows that
just visiting the beach did not appear to
adversely affect health for persons with asthma
during periods of no red tide, despite relatively
low temperatures and strong winds; in the past,
these environmental factors have been associ-
ated with increased bronchoconstriction among
asthmatics (Koh and Choi 2002). In fact, addi-
tional analysis of data collected on a subsequent
unexposed warmer and more humid day in
May 2004 (data not shown) illustrated that
there was some effect of the cold temperatures
in the January 2003 nonexposure period on the
lung function of the asthmatics; however, the
March 2003 Florida red tide toxin exposure
caused substantial significant respiratory
changes in the asthmatics.
In this preliminary study, the asthmatics
who appeared to be at greatest risk for a statis-
tically significant respiratory decrease after
exposure to Florida red tide were those who
chronically used medications. As discussed
above, although precisely defining the asthma
severity is not possible without an untreated
unexposed baseline assessment of all the asth-
matics, the most severe asthmatics in this
study population are probably those who
reported regular use of medications within
12 hr of going to the beach for the study.
These more severe asthmatics had the most
significant decreases in respiratory function
during Florida red tide exposure among all the
study participants. Furthermore, the effects of
other possible factors (i.e., age, sex, and resi-
dence proximity to the shore) were less impor-
tant when the data were stratified by use of
medication. Therefore, the results suggest that
the more severe asthmatics were the most sen-
sitive to Florida red tide toxin exposure.
Preliminary work with an asthmatic sheep
model has indicated that pretreatment with
regularly used asthma medications (i.e., cro-
molyn, albuterol, and even antihistamines)
minimize the respiratory depressive effects of
brevetoxins and of Florida red tide aerosol.
Therefore, the respiratory decreases in partici-
pants with more severe asthma in this study
might have actually been much greater if they
had not premedicated.
The brevetoxin dose to which the study
participants were exposed was relatively low,
with an average ambient air concentration on
the beach even during the highest exposure day
(29 March) of 36.67 ± 17.54 ng/m3. In a prior
study of recreational beachgoers by these inves-
tigators, this was considered “moderate” expo-
sure compared with a “high” exposure day with
up to 108 ng/m3 of brevetoxin in the air
(Backer et al. 2003, 2005). If an average adult
at rest breathes in about 6 L of air per minute
(Guyton 1981), then persons visiting the
beaches during this study on the highest expo-
sure day inhaled approximately 12.9 ng of
brevetoxin each hour, or an inhaled dose of
0.18 ng/kg (assuming an average weight of
70 kg) each hour. Franz and LeClaire (1989)
reported respiratory failure in < 3 min in guinea
pigs exposed intravenously to 0.016 ng/kg
brevetoxin 3, and Benson et al. (1999) exposed
12-week-old male F344/Crl BR rats to a single
dose of 6.6 µg/kg brevetoxin 3 through intra-
tracheal instillation resulted in systemic distrib-
ution of brevetoxin 3 lasting more than 7 days
postexposure. Singer et al. (1998) and Abraham
et al. (2003, 2005) have found that intratra-
cheal administration of picogram doses of both
brevetoxins and aerosolized Florida red tide
samples caused significant respiratory depres-
sion in asthmatic sheep. Therefore, aerosolized
Florida red tide and brevetoxins appear to be
significant respiratory toxins at very low expo-
sures in both humans and animals.
The physiologic impact of exposure to the
Florida red tide aerosol depends on the mass
and chemical characteristics of the inhaled
particles. In a similar study of red tide aerosols
conducted in Texas (Cheng et al. 2005a) and
in the present study (Cheng et al. 2005b;
Pierce et al., in press), the particles containing
brevetoxin were 2.9–15 µm in mass median
aerodynamic diameter. Inhaled particles of
this size would be deposited primarily in the
upper respiratory tract (Schlesinger 1985);
subsequent respiratory irritation could result
from the impact of the particles themselves
and/or from the toxins associated with the
particles. In the present study, the reported
respiratory irritation and the measured
decreases in respiratory function were caused
by exposure to aerosolized Florida red tide and
brevetoxins; in general, the study participants
did not report symptoms or have measured
respiratory decreases during nonexposure to
Florida red tide, but they did when brevetox-
ins were measured in the environmental air
sampling, as well as in their noses, using the
newly developed ELISA for brevetoxins.
Possible chronic effects from exposure to
aerosolized Florida red tide and brevetoxins
may occur and should be evaluated. The swab
inflammatory data suggest a possible delayed
increased effect among the sensitive subpopula-
tion after the beginning of red tide exposure.
Anecdotally, several of the asthmatic partici-
pants have reported delayed effects after their
Florida red tide beach exposures. This is further
supported by another study (Quirino et al.
2004) using Florida Poison Information Center
data to compare persons calling with Florida
red tide–associated symptoms with unexposed
control callers. Callers with Florida red tide
exposure reported significantly more respiratory
symptoms at the time of exposure, and a signifi-
cantly longer duration of these symptoms
(12.84 ± 25.35 days duration of symptoms
compared with 2 ± 1.41 days for the unexposed
callers). Also, callers exposed to Florida red tide
were significantly more likely than unexposed
callers to report seeking medical care (an
elevated relative risk of 3.00; p < 0.025).
Study limitations and strengths. This study
has several limitations. First, exposure to
aerosolized Florida red tide is difficult to assess.
It is a natural event with significant variation
over time and space caused by the ongoing
effects of seawater concentrations, wind direc-
tion and speed, and other environmental fac-
tors. Furthermore, the aerosol is a mixture of
seawater and salt, various brevetoxins, cellular
particles, and other substances as yet to be
defined. For example, the study investigators
have discovered that K. brevis produces a
natural inhibitor of brevetoxin, known as
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brevenol; brevenol was measured during the
March 2003 study period on the environmen-
tal air samplers (Bourdelais et al. 2004; Cheng
et al. 2005b; Pierce et al., in press; Purkerson-
Parker et al. 2000). The exact constituents of
Florida red tide aerosols and their individual
and combined effects on humans and other
animals need further evaluation.
This study took place in an area with
annual Florida red tide exposure. Defining a
complete unexposed period was not possible
because there were K. brevis cells in the waters
along the beach study site even during the
“unexposed” period. Furthermore, the partici-
pants were all residents of this area, and many
had a history of Florida red tide exposure.
Therefore, these participants may have experi-
enced intermittent Florida red tide aerosol
exposure unmeasured by the investigators
before, after, and during the two study peri-
ods. In addition, residents of this geographic
region may have adapted to chronic Florida
red tide aerosol exposure.
Techniques to measure human exposure
and subsequent adverse health effects from
exposure to aerosolized Florida red tide toxins
are currently under development. The newly
developed brevetoxin ELISA, as well as LC-MS
and HPLC, were close to their LODs even
during the Florida red tide exposure period;
this was particularly true for the relatively low-
flow personal air monitoring and for the swabs.
The use of throat and nose swabs to evaluate
inflammatory change is also under develop-
ment. Nevertheless, these methodologies offer
the possibility of quantitative and objective
measurement with both exposure and effect
biomarkers of brevetoxins in humans in the
future, in addition to the more traditional
exposure assessment (i.e., water, environmental
air, personal air) and health effect assessment
(i.e., questionnaire and spirometry).
In this initial study, the asthmatic partici-
pants were evaluated without Florida red tide
exposure but not without the use of their
medications. This is important for several rea-
sons. Preliminary data using an asthmatic
sheep animal model have shown that pretreat-
ment with commonly used asthma medica-
tions (i.e., albuterol, atropine, cromolyn, and
even antihistamines) can minimize the effects
of brevetoxins and of Florida red tide aerosols
on respiratory function (Abraham et al. 2005).
Therefore, the ongoing use of asthma medica-
tions among the participants with more severe
asthma may have decreased the physiologic
effects of Florida red tide exposure in the most
sensitive subpopulation.
In addition to the advantage of employing
the objective effect measure of spirometry, this
study used a methodology in which each sub-
ject served as his or her own control with
regards to all effect measures, before and after
1 hr of beach exposure as well as during
Florida red tide exposed and unexposed peri-
ods. This methodology has been used exten-
sively looking at cross-shift and at longitudinal
changes in respiratory function (Anees 2003;
Chan-Yeung 2000; Eisen et al. 1997; Hnizdo
et al. 1999; Skogstad et al. 2002; Waters et al.
2003) in occupational studies of respiratory
toxins, as well as in environmental air pollu-
tion studies (Desqueyroux et al. 2002).
The strengths of this preliminary study
of sensitive population and exposure to aero-
solized Florida red tide outweigh its limitations.
This study integrated extensive environmental
assessment with evaluation of adverse human
health effects. It is the first study to objectively
measure both exposure and adverse health
effects in a relatively large population of per-
sons with underlying respiratory disease.
Finally, although small, the objectively mea-
sured respiratory decreases were statistically sig-
nificant and correlated with the both the
environmental assessment and with the self-
reported respiratory symptoms.
The investigators plan to evaluate the
possible chronic effects of exposure to
aerosolized Florida red tide toxins among the
sensitive subpopulations. Not all persons with
asthma may be equally sensitive to toxin
exposures. In addition, evaluation of possible
therapeutic interventions using animal models,
as well as controlled trials in humans, needs to
be explored.
REFERENCES
Abraham WM, Ahmed A, Bourdelais AJ, Baden DG. 2003.
Pathophysiologic airway responses to inhaled red tide
brevetoxin in allergic sheep [Abstract]. Toxicology 72:115.
Abraham WM, Bourdelais AJ, Ahmed A, Sereberiakov I, Baden
DG. 2005. Effects of inhaled brevetoxins in allergic air-
ways: toxin–allergen interactions and pharmacologic
intervention. Environ Health Perspect 113:632–637.
American Thoracic Society. 1991. Lung function testing: selec-
tion of reference values and interpretive strategies. Am
Rev Respir Dis 144:1202–1218.
American Thoracic Society. 1995. Standardization of spirome-
try 1994 update. Am J Respir Crit Care Med 152:1107–1136.
Anees W. 2003. Use of pulmonary function tests in the diagno-
sis of occupational asthma. Ann Allergy Asthma Immunol
90(5 suppl 2):47–51.
Asai S, Krzanowski JJ, Anderson WH, Martin DF, Polson JB,
Lockey RF, et al. 1982. Effects of the toxin of red tide,
Ptychodiscus brevis, on canine tracheal smooth muscle: a
possible new asthma triggering mechanism. J Allergy Clin
Immunol 69:418–428.
Backer LC, Fleming LE, Rowan A, Cheng YS, Benson J, Pierce
R, et al. 2003. Recreational exposure to aerosolized breve-
toxins during Florida red tide events. Harmful Algae
2:19–28.
Backer LC, Kirkpatrick B, Fleming LE, Cheng YS, Pierce R, Bean
JA, et al. 2005. Occupational exposure to aerosolized breve-
toxins during Florida red tide events: effects on a healthy
worker population. Environ Health Perspect 113:644–649.
Baden D, Fleming LE, Bean JA. 1995. Marine Toxins. In:
Handbook of Clinical Neurology: Intoxications of the
Nervous System. Part H. Natural Toxins and Drugs
(DeWolf FA, ed). Amsterdam:Elsevier Press, 141–175.
Baden DG. 1983. Marine food-borne dinoflagellate toxins. Int
Rev Cytol 82:99–150.
Baden DG, Bourdelais AJ, Jacocks H, Michelizza S, Naar J.
2005. Natural and derivative brevetoxins: historical back-
ground, multiplicity, and effects. Environ Health Perspect
113:621–625.
Benson J, Tischler D, Baden D. 1999. Uptake, tissue distribu-
tion, and excretion of brevetoxin 3 administered to rats by
intratracheal instil lation. J Toxicol Environ Health
56:345–355.
Benson JM, Hahn FF, March TH, McDonald JD, Gomez AP,
Sopori MJ, et al. 2005. Inhalation toxicity of brevetoxin 3 in
rats exposed for twenty-two days. Environ Health
Perspect 113:626–631.
Bossart GD, Baden DG, Ewing R, Roberts B, Wright S. 1998.
Brevetoxicosis in manatees (Tnchechus manatus
latirostris) from the 1996 epizootic: gross, histopathologic
and immunocytochemical features. Toxicol Pathol
26(2):276–282.
Bourdelais AJ, Campbell S, Jacocks H, Naar J, Wright J, Carsi
J, et al. 2004. Brevenal is a natural inhibitor of brevetoxin
action in sodium channel receptor binding assays. Cell
Mol Neurobiol 24(4):553–563.
Chan-Yeung M. 2000. Spirometry and tests of bronchial hyper-
responsiveness in population studies. Int J Tuberculosis
Lung Dis 4(7):633–638.
Cheng YS, Villareal TA, Zhou Y, Gao J, Pierce RH, Wetzel D,
et al. 2005a. Characterization of red tide aerosol on the
Texas coast. Harmful Algae.
Cheng YS, Zhou Y, Irvin CM, Pierce RH, Naar J, Backer LC,
et al. 2005b. Characterization of marine aerosol for assess-
ment of human exposure to brevetoxins. Environ Health
Perspect 112:000–000.
Desqueyroux H, Pujet JC, Prosper M, Squinazi F, Momas I.
2002. Short-term effects of low-level air pollution on respi-
ratory health of adults suffering from moderate to severe
asthma. Environ Res 89(1):29–37.
Eisen EA, Holcroft CA, Greaves IA, Wegman DH, Woskie SR,
Monson RR. 1997. A strategy to reduce healthy worker
effect in a cross-sectional study of asthma and metal-
working fluids. Am J Ind Med 31(6):671–677.
Fleming LE, Bean JA, Katz D, Hammond R. 2001. The epidemiol-
ogy of seafood poisoning. In: Seafood and Environmental
Toxins (Hui, Kits, Stanfield, eds). New York:Marcel Dekker,
287–310.
Franz DR, LeClaire RD. 1989. Respiratory effects of brevetoxin
and saxitoxin in awake guinea pigs. Toxicon 27:647–654.
Guyton AC. 1981. Textbook of Medical Physiology. Philadelphia:
WB Saunders, 483.
Hankinson JL, Odencrantz JR, Fedan KB. 1999. Spirometric ref-
erence values from a sample of the general U.S. popula-
tion. Am J Respir Crit Care Med 159:179–187.
Hnizdo E, Churchyard G, Barnes D, Dowdeswell R. 1999.
Assessment of reliability of lung function screening pro-
grams or longitudinal studies. Am J Respir Crit Care Med
160(6):2006–2011.
Kirkpatrick B, Fleming L, Squicciarini D, Backer L, Clark R,
Abraham W, et al. 2004. Literature review of Florida red
tide: implications for human health. Harmful Algae
3(2):99–115.
Kirkpatrick B, Hautamaki R, Kane T, Henry M. 2001. A pilot study
to explore the occupational exposure to Gymnodinium
brevetoxin and pulmonary function. In: Harmful Algal
Blooms. Proceedings of the 9th International Conference
on Harmful Algal Blooms, 7–11 February 2000, Holbart,
Tasmania (Hallegraeff GM, Bolch CJ, Blackburn SI, Lewis
RJ, eds). Paris:International Oceanographic Commission of
UNESCO, 447–450.
Kleinbaum DG, Kupper LL, Morgenstern H. 1982. Epidemiologic
Research. New York:Van Nostrand Reinhold, 388–396.
Koh YI, Choi IS. 2002. Seasonal difference in the occurrence of
exercise-induced bronchospasm in asthmatics: depen-
dence on humidity. Respiration 69(1):38–45.
Morris P, Campbell DS, Taylor TJ, Freeman JI. 1991. Clinical
and epidemiological features of neurotoxic shellfish poi-
soning in North Carolina. Am J Public Health 81:471–3.
Music SI, Howell JT, Brumback LC. 1973. Red tide: its public
health implications. FL Med J 60(11):27–29.
Naar J, Bourdelais A, Tomas C, Kubanek J, Whitney PL,
Flewelling L, et al. 2002. A competitive ELISA to detect
brevetoxins from Karenia brevis (formerly Gymnodinium
breve) in seawater, shellfish, and mammalian body fluid.
Environ Health Perspect 110:179–185.
NIOSH. 1997. NIOSH Spirometry Training Guide. Morgantown,
WV:National Institute for Occupational Safety and Health.
Pierce RH, Henry MS, Bloom PC, Hamel SL, Kirkpatrick B,
Cheng YS, et al. In press. Brevetoxin composition in water
and marine aerosol along a Florida beach: assessing
potential human exposure to marine biotoxins. Harmful
Algae.
Mini-Monograph | Fleming et al.
656 VOLUME 113 | NUMBER 5 | May 2005 • Environmental Health Perspectives
Mini-Monograph | Asthma and Florida red tide toxins
Environmental Health Perspectives • VOLUME 113 | NUMBER 5 | May 2005 657
Pierce RH, Henry MS, Blum P, Lyons J, Cheng YS, Yazzie D,
et al. 2003. Brevetoxin concentrations in marine aerosol:
human exposure levels during a K. brevis harmful algal
bloom. Bull Environ Contam Toxicol 70(1):161–165.
Pierce RH, Henry MS, Proffitt LS, Hasbrouck PA. 1990. Red tide
toxin (brevetoxin) enrichment in marine aerosol. In: Toxic
Marine Phytoplankton (Graneli E, Sundstron S, Elder L,
Anderson DM, eds). New York:Elsevier Scientific
Publishing, 397–402.
Pierce RH, Kirkpatrick GJ. 2001. Innovative techniques for harm-
ful algal toxin analysis. Environ Toxicol Chem 20(1):107–114.
Poli MA, Musser SM, Dickey RW, Eilers PP, Hall S. 2000.
Neurotoxic shellfish poisoning and brevetoxin metabolites:
a case study from Florida. Toxicon 38(7):981–993.
Purkerson-Parker SL, Fieber LA, Rein KS, Podona T, Baden D.
2000. Brevetoxin derivatives that inhibit toxin activity.
Chem Biol 7(6):385–393.
Quirino W, Fleming LE, Weisman R, Backer L, Kirkpatrick B,
Clark R , et al. 2004. Follow up of red tide associated respi-
ratory illness. Fl J Environ Health 86:18–22.
Schlesinger RB. 1985. Comparative deposition of inhaled
aerosols in experimental animals and humans: a review.
J Toxicol Environ Health 15:197–214.
Singer LJ, Lee T, Rosen KA, Baden DG, Abraham WM. 1998.
Inhaled Florida red tide toxins induce bronchoconstriction
(BC) and airway hyperresponsiveness (AHR) in sheep
[Abstract]. Am J Respir Crit Care Med 157(3):A158.
Skogstad M, Thorsen E, Haldorsen T, Kjuus H. 2002. Lung func-
tion over six years among professional divers. Occup
Environ Med 59(9):629–633.
Steidinger KA, Baden DG. 1984. Toxic marine dinoflagellates.
In: Dinoflagellates (Spector DL, ed). New York:Academy
Press, 201–261.
Waters A, Beach J, Abramson M. 2003. Symptoms and lung
function in health care personnel exposed to glutaralde-
hyde. Am J Ind Med 43(2):196–203.
Wells JH, Lerner MR, Martin DF, Strecker RA, Lockey RF. 1984.
The effect of respiratory exposure to red tide toxin on air-
way resistance in conscious guinea pigs [Abstract].
J Allergy Clin Immunol 73(1):128.
Woodcock AH. 1948. Note concerning human respiratory irrita-
tion associated with high concentrations of plankton and
mass mortality of marine organisms. J Marine Res 7:56–62.
